NCT04748939View on ClinicalTrials.gov

Shingrix in Patients With Rheumatic Diseases: a Double-blind Placebo-controlled RCT

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

July 31, 2026

Conditions
Herpes Zoster
Interventions
BIOLOGICAL

recombinant subunit herpes zoster vaccine

vaccine administration

Trial Locations (1)

Unknown

Department of Medicine, Tuen Mun Hospital, Hong Kong

All Listed Sponsors
lead

Tuen Mun Hospital

OTHER_GOV